{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "DecreaseAmount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O75923",
      "entity_text" : "Dysferlin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0642" ],
      "Cellular_component" : [ "go:GO:0045202" ],
      "Species" : [ "taxonomy:10090" ]
    }
  },
  "verbose_text" : "While our findings above suggest a weak RNS CMAP decrement and loss of muscle strength associated with loss of Dysferlin, LGMD2B patients are not thought to exhibit fatigueability and are often sportive through childhood and early adult years, which indicates that LGMD2B is not a classical myasthenic syndrome.",
  "reading_complete" : "2020-08-04T10:22:39Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T10:21:30Z",
  "trigger" : "loss",
  "evidence" : [ "loss of Dysferlin" ],
  "pmc_id" : "3828772",
  "score" : 0
}